NO994440L - Fremgangsmåte ved påvisning av tidlig magekreft - Google Patents

Fremgangsmåte ved påvisning av tidlig magekreft

Info

Publication number
NO994440L
NO994440L NO994440A NO994440A NO994440L NO 994440 L NO994440 L NO 994440L NO 994440 A NO994440 A NO 994440A NO 994440 A NO994440 A NO 994440A NO 994440 L NO994440 L NO 994440L
Authority
NO
Norway
Prior art keywords
gastric cancer
cox
procedure
detection
early gastric
Prior art date
Application number
NO994440A
Other languages
English (en)
Norwegian (no)
Other versions
NO994440D0 (no
Inventor
Ari Ristimoki
Matti Horkoenen
Pentti Sipponen
Original Assignee
Locus Genex Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locus Genex Oy filed Critical Locus Genex Oy
Publication of NO994440D0 publication Critical patent/NO994440D0/no
Publication of NO994440L publication Critical patent/NO994440L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57446Specifically defined cancers of stomach or intestine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO994440A 1997-03-18 1999-09-13 Fremgangsmåte ved påvisning av tidlig magekreft NO994440L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI971124A FI971124A0 (fi) 1997-03-18 1997-03-18 Metod foer diagnostisering av magcancer
PCT/FI1998/000238 WO1998041864A1 (fr) 1997-03-18 1998-03-18 Diagnostic precoce du cancer gastrique

Publications (2)

Publication Number Publication Date
NO994440D0 NO994440D0 (no) 1999-09-13
NO994440L true NO994440L (no) 1999-11-18

Family

ID=8548414

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994440A NO994440L (no) 1997-03-18 1999-09-13 Fremgangsmåte ved påvisning av tidlig magekreft

Country Status (20)

Country Link
US (1) US6416961B1 (fr)
EP (1) EP0968421B1 (fr)
JP (1) JP2001519900A (fr)
KR (1) KR20000076291A (fr)
CN (1) CN1250523A (fr)
AT (1) ATE272838T1 (fr)
AU (1) AU732228B2 (fr)
BR (1) BR9808378A (fr)
CA (1) CA2284048A1 (fr)
DE (1) DE69825431T2 (fr)
DK (1) DK0968421T3 (fr)
ES (1) ES2226105T3 (fr)
FI (1) FI971124A0 (fr)
IL (1) IL131594A (fr)
NO (1) NO994440L (fr)
NZ (1) NZ338068A (fr)
PT (1) PT968421E (fr)
RU (1) RU2204835C2 (fr)
TR (1) TR199902298T2 (fr)
WO (1) WO1998041864A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335193B1 (en) * 1999-04-15 2002-01-01 Padmanabhan P Nair Isolated colonocytes
WO2001051660A2 (fr) * 2000-01-14 2001-07-19 Vera Genics Ltd. Methode et kit de diagnostic de transformation neoplastique
EP2949762B1 (fr) * 2000-03-27 2018-05-09 Thomas Jefferson University Compositions pour le traitement de cellules cancereuses stomacales et oesophagiennes
US20020068307A1 (en) * 2000-03-30 2002-06-06 Jason Pluta Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
WO2003001183A2 (fr) * 2001-06-25 2003-01-03 Oncomedx, Inc. Methodes de detection et de surveillance du taux d'arn de cox-2 dans le plasma et le serum
WO2003060121A2 (fr) * 2001-12-21 2003-07-24 Diadexus, Inc. Compositions et procedes relatifs a des proteines et a des genes gastriques specifiques
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
WO2004007770A2 (fr) * 2002-07-10 2004-01-22 Oncotherapy Science, Inc. Procede de diagnostic de tumeurs gastriques de type intestinal
AU2003263607A1 (en) * 2002-10-25 2004-05-13 Japan As Represented By The President Of The University Of Tokyo Method for diagnosing diffuse-type gastric cancer
NZ544977A (en) * 2003-07-17 2009-07-31 Pacific Edge Biotechnology Ltd Cystatin SN ("CST1") as a marker for detection of gastric cancer
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
US20050075543A1 (en) * 2003-10-03 2005-04-07 Calabrese Charles A. Method of anonymous medical testing and providing the patient with the test results
KR100645979B1 (ko) * 2004-08-09 2006-11-15 한국생명공학연구원 위암 유전자 마커 및 이를 이용한 위암 진단킷트
US20080032943A1 (en) * 2005-11-04 2008-02-07 Johji Inazawa Method for detecting cancer and a method for suppressing cancer
RU2613139C1 (ru) * 2015-10-12 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ дифференциальной диагностики рака желудка различных гистологических типов
RU2613300C1 (ru) * 2015-11-10 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики низко дифференцированного нейроэндокринного рака желудка
RU2642989C1 (ru) * 2016-12-19 2018-01-29 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") Способ диагностики онкологических заболеваний
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
RU2743221C1 (ru) * 2020-10-12 2021-02-16 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ определения типа рака желудка по классификации lauren методом компьютерной томографии

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459239A (en) 1994-01-24 1995-10-17 Merck Frosst Canada Inc. Peptide sequences and antipeptide antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 proteins

Also Published As

Publication number Publication date
CA2284048A1 (fr) 1998-09-24
EP0968421B1 (fr) 2004-08-04
CN1250523A (zh) 2000-04-12
IL131594A0 (en) 2001-01-28
NO994440D0 (no) 1999-09-13
KR20000076291A (ko) 2000-12-26
IL131594A (en) 2004-02-19
ATE272838T1 (de) 2004-08-15
EP0968421A1 (fr) 2000-01-05
AU6404198A (en) 1998-10-12
WO1998041864A1 (fr) 1998-09-24
TR199902298T2 (xx) 2000-01-21
DK0968421T3 (da) 2004-12-06
DE69825431D1 (de) 2004-09-09
AU732228B2 (en) 2001-04-12
NZ338068A (en) 2001-03-30
RU2204835C2 (ru) 2003-05-20
PT968421E (pt) 2004-10-29
FI971124A0 (fi) 1997-03-18
JP2001519900A (ja) 2001-10-23
BR9808378A (pt) 2000-05-23
ES2226105T3 (es) 2005-03-16
US6416961B1 (en) 2002-07-09
DE69825431T2 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
NO994440D0 (no) FremgangsmÕte ved pÕvisning av tidlig magekreft
DK0667920T3 (da) Fremgangsmåder til påvisning af prostatacancermetastase
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
CA2072314A1 (fr) Methodes de detection des metastases par l'amplification de l'acide nucleique
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
JP2002541481A5 (fr)
WO2000056352A3 (fr) Reactifs et procedes utiles pour detecter les maladies de la prostate
ATE419516T1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
WO2003001183A3 (fr) Methodes de detection et de surveillance du taux d'arn de cox-2 dans le plasma et le serum
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
DK0958500T3 (da) Immunohistokemisk påvisningsassay for carcinomproliferationsstatus
WO2002004952A3 (fr) Methodes diagnostiques et therapeutiques basees sur la molecule d'adhesion l1 pour le traitement d'une tumeur de l'ovaire ou de l'endometre
WO2004084804A3 (fr) Methodes, compositions et trousses pour la detection et pour la surveillance d'un cancer du poumon
HUP9801448A2 (hu) Eljárás antitesttermelés kimutatására
WO2001063293A8 (fr) Proteines et genes et leur utilisation dans le diagnostic et le traitement de la schizophrenie
WO2001002828A3 (fr) Diagnostic du cancer par detection de polynucleotides ou de polypeptides ash2
WO1998021365A3 (fr) Procede de detection du cancer de la prostate metastatique
WO2004002294B1 (fr) Marqueur plasmatique ou serique et procede pour detecter un cancer
WO2001065262A3 (fr) Reactifs et methodes de detection des pathologies mammaires
FI961678A0 (fi) Alukkeita ja koettimia CMV:n nukleiinihapon monistamiseksi ja havaitsemiseksi
AU2001285157A1 (en) 5t4 rna in plasma and serum as a marker for neoplastic disease
CN108548922B (zh) 检测yap k342甲基化修饰的试剂及其应用
Shioya et al. Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay
AU4182697A (en) Use of prostate tumor inducing gene for detection of cancer cells

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application